Investigating the C2 Modulation of the Imidazo[1,2‐ a ]pyrazine‐Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition

Lhana Tisseur, Sandrine Cojean, Khadidiatou Gassama, Cédric Logé, Fabrice Pagniez, Christian Cavé, Guillaume Bernadat, Philippe M. Loiseau, Stéphane Bach, Jérôme Thiéfaine, Carine Picot, Christophe Tomasoni, Olivier Leclercq, Blandine Baratte, Thomas Robert, Patrice Le Pape, Najma Rachidi, Marc‐Antoine Bazin, Pascal Marchand

Open source

DOI: 10.1002/cmdc.202400862
Published: 2025-01-06
Container: ChemMedChem
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cmdc.202400862,
  title = {Investigating the C2 Modulation of the Imidazo[1,2‐
                    <i>a</i>
                    ]pyrazine‐Based Hit Compound CTN1122: Synthesis,
                    <i>in vitro</i>
                    Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition},
  author = {Lhana Tisseur and Sandrine Cojean and Khadidiatou Gassama and Cédric Logé and Fabrice Pagniez and Christian Cavé and Guillaume Bernadat and Philippe M. Loiseau and Stéphane Bach and Jérôme Thiéfaine and Carine Picot and Christophe Tomasoni and Olivier Leclercq and Blandine Baratte and Thomas Robert and Patrice Le Pape and Najma Rachidi and Marc‐Antoine Bazin and Pascal Marchand},
  year = {2025},
  journal = {ChemMedChem},
  doi = {10.1002/cmdc.202400862},
  url = {https://doi.org/10.1002/cmdc.202400862}
}

RIS

TY  - JOUR
TI  - Investigating the C2 Modulation of the Imidazo[1,2‐
                    <i>a</i>
                    ]pyrazine‐Based Hit Compound CTN1122: Synthesis,
                    <i>in vitro</i>
                    Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition
AU  - Lhana Tisseur
AU  - Sandrine Cojean
AU  - Khadidiatou Gassama
AU  - Cédric Logé
AU  - Fabrice Pagniez
AU  - Christian Cavé
AU  - Guillaume Bernadat
AU  - Philippe M. Loiseau
AU  - Stéphane Bach
AU  - Jérôme Thiéfaine
AU  - Carine Picot
AU  - Christophe Tomasoni
AU  - Olivier Leclercq
AU  - Blandine Baratte
AU  - Thomas Robert
AU  - Patrice Le Pape
AU  - Najma Rachidi
AU  - Marc‐Antoine Bazin
AU  - Pascal Marchand
PY  - 2025
JO  - ChemMedChem
DO  - 10.1002/cmdc.202400862
UR  - https://doi.org/10.1002/cmdc.202400862
ER  -

APA

Tisseur, L., Cojean, S., Gassama, K., Logé, C., Pagniez, F., Cavé, C., Bernadat, G., Loiseau, P. M., Bach, S., Thiéfaine, J., Picot, C., Tomasoni, C., Leclercq, O., Baratte, B., Robert, T., Pape, P. L., Rachidi, N., Bazin, M., & Marchand, P. (2025). Investigating the C2 Modulation of the Imidazo[1,2‐ a ]pyrazine‐Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition. ChemMedChem. https://doi.org/10.1002/cmdc.202400862

Source records

crossref · retrieved 2026-09-27T06:14:49.369Z

Investigating the C2 Modulation of the Imidazo[1,2‐ <i>a</i> ]pyrazine‐Based Hit Compound CTN1122: Synthesis, <i>in vitro</i> Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition

Credibility signals

Cite this work

BibTeX

RIS

APA

Source records